Latest Listings And Ipos News

Challenger Limited celebrates four decades with a robust 9% rise in net profit and a strategic digital transformation, positioning itself at the forefront of Australia’s retirement income market.

CSL Limited reported solid FY25 financials with 5% revenue growth and announced a strategic transformation including a $500 million annual cost saving target and plans to spin off its vaccine business, CSL Seqirus, as a separate ASX-listed entity.

CSL Limited reported robust FY25 results alongside a sweeping strategic overhaul, including a major cost-saving program and plans to spin off its vaccine unit CSL Seqirus as a standalone ASX-listed company.

CSL Limited posted a 14% rise in net profit for FY2025, underpinned by strong immunoglobulin sales and new product launches, while announcing plans to demerge its vaccines business, CSL Seqirus, to sharpen strategic focus.

HMC Capital reported a robust FY25 with a 51% rise in operating EPS and a 47% jump in assets under management to $18.7 billion, driven by expansion across multiple funds management divisions.

HMC Capital has reported a record FY25 with pre-tax operating earnings soaring 74% and EPS up 51%, driven by strong asset growth and diversified platform success. The company sets a confident FY26 outlook targeting sustained organic growth and stable dividends.

HMC Capital Limited reported a record FY25 profit of $265.2 million, driven by strategic acquisitions and growth in digital infrastructure and energy transition sectors. The company also declared a consistent dividend and strengthened its balance sheet with an increased undrawn debt facility.

Kaili Resources addresses ASX price query following a dramatic surge in its share price and trading volume, attributing the movement to its recent rare earth element drilling approval in South Australia.

Platinum Asia Investments Limited (PAI) shares have been suspended following Federal Court approval of a scheme exchanging all shares for units in the Platinum Asia Fund Complex ETF (PAXX). This marks a significant structural shift for PAI investors.

Peak Rare Earths Limited has entered a scheme of arrangement with Shenghe Resources (Singapore) Pte. Ltd., valuing the company at approximately A$158 million. The scheme offers Peak shareholders a cash consideration of no less than A$0.359 per share, representing a 199% premium to the last closing price.

Lake Resources has successfully raised up to A$12 million through a strongly supported placement, bolstering its financial position to advance the Kachi lithium project in Argentina.

Kaili Resources has addressed a sharp spike in its share price and trading volume, attributing the market interest to its recent approval for rare earth element drilling in South Australia, while confirming no undisclosed material information.